Using human induced pluripotent stem cells (hiPSCs) to investigate the mechanisms by which Apolipoprotein E (APOE) contributes to Alzheimer’s disease (AD) risk
Open Access
- 1 May 2020
- journal article
- review article
- Published by Elsevier in Neurobiology of Disease
- Vol. 138, 104788
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
This publication has 277 references indexed in Scilit:
- Proteolytic Cleavage of Apolipoprotein E4 as the Keystone for the Heightened Risk Associated with Alzheimer’s DiseaseInternational Journal of Molecular Sciences, 2013
- Aging and reprogramming: a two-way streetCurrent Opinion in Cell Biology, 2012
- Playing the End Game: DNA Double-Strand Break Repair Pathway ChoiceMolecular Cell, 2012
- APOE genotype alters glial activation and loss of synaptic markers in miceGlia, 2012
- The N141I Mutation in PSEN2Archives of Neurology, 2010
- Astrocytes: biology and pathologyActa Neuropathologica, 2009
- Soluble Oligomers of Amyloid β Protein Facilitate Hippocampal Long-Term Depression by Disrupting Neuronal Glutamate UptakeNeuron, 2009
- Distinct Pools of β-Amyloid in Alzheimer Disease–Affected BrainArchives of Neurology, 2008
- ApoE Promotes the Proteolytic Degradation of AβNeuron, 2008
- Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined FactorsCell, 2007